Abstract
In recent years, nanocarriers have played increasingly significant roles in cancer therapy. Among various nanoplatforms, mesoporous silica nanoparticles (MSNs) have been given serious attention due to their good colloidal stablity, tunable pore sizes, extensive drug loading capacity and easily modified surface. In this review, functionalized MSNs are introduced as an efficient nanocarrier for cancer treatment. First, MSN preparation strategies are generally introduced. Next, passive and active tumor targeting methods for the functionalization of MSNs are reviewed. Then, several types of stimuli-responsive strategies for on-demand drug release, a wide variety of designs integrating with magnetic resonance imaging agents, optical imaging agents, and positron emission tomography imaging agents, etc. for theranostic purpose are summarized. A discussion relating to the future perspectives of MSNs for clinical translocation is also included in this review.
Keywords: Mesoporous silica nanoparticles, functionalization, tumor targeting, stimuli-responsive, drug delivery, theranostics.
Current Pharmaceutical Design
Title:Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics
Volume: 23 Issue: 23
Author(s): Wenjia Zhang, Mengrui Liu, Anchang Liu*Guangxi Zhai*
Affiliation:
- Department of Pharmacy, Qilu Hospital of Shandong University, P.O. Box: 250012, Jinan,China
- Department of Pharmaceutics, College of Pharmacy, Shandong University, P.O Box: 250012, Jinan,China
Keywords: Mesoporous silica nanoparticles, functionalization, tumor targeting, stimuli-responsive, drug delivery, theranostics.
Abstract: In recent years, nanocarriers have played increasingly significant roles in cancer therapy. Among various nanoplatforms, mesoporous silica nanoparticles (MSNs) have been given serious attention due to their good colloidal stablity, tunable pore sizes, extensive drug loading capacity and easily modified surface. In this review, functionalized MSNs are introduced as an efficient nanocarrier for cancer treatment. First, MSN preparation strategies are generally introduced. Next, passive and active tumor targeting methods for the functionalization of MSNs are reviewed. Then, several types of stimuli-responsive strategies for on-demand drug release, a wide variety of designs integrating with magnetic resonance imaging agents, optical imaging agents, and positron emission tomography imaging agents, etc. for theranostic purpose are summarized. A discussion relating to the future perspectives of MSNs for clinical translocation is also included in this review.
Export Options
About this article
Cite this article as:
Zhang Wenjia, Liu Mengrui, Liu Anchang*, Zhai Guangxi*, Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics, Current Pharmaceutical Design 2017; 23 (23) . https://dx.doi.org/10.2174/1381612822666161025153619
DOI https://dx.doi.org/10.2174/1381612822666161025153619 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked
Current Pharmaceutical Design Roles of Fluorine in Drug Design and Drug Action
Letters in Drug Design & Discovery Proteostasis, an Emerging Therapeutic Paradigm for Managing Inflammatory Airway Stress Disease
Current Molecular Medicine Expression Profiling of Estrogen Responsive Genes Using Genomic and Proteomic Techniques for the Evaluation of Endocrine Disruptors
Current Pharmacogenomics The Anterior Gradient-2 Pathway as a Model for Developing Peptide-Aptamer Anti-Cancer Drug Leads that Stimulate p53 Function
Current Chemical Biology Gene Transfer for Inborn Errors of Metabolism of the Liver: The Clinical Perspective
Current Pharmaceutical Design MicroRNA Therapies for Osteoarthritis and its Symptoms
Current Tissue Engineering (Discontinued) CDC25 Inhibitors as Anticancer Agents Are Moving Forward
Anti-Cancer Agents in Medicinal Chemistry Possible Neuroprotective Strategies in ALS
Current Neuropharmacology Understanding the Cardiovascular Actions of Soy Isoflavones: Potential Novel Targets for Antihypertensive Drug Development
Cardiovascular & Hematological Disorders-Drug Targets Synthesis of ST7612AA1, a Novel Oral HDAC Inhibitor, via Radical Thioacetic Acid Addition
Current Bioactive Compounds Editorial (Thematic Issue: Cancer Biomarkers from Bench to Bedside)
Current Cancer Drug Targets Delirium in Older Patients – A Review
Current Psychiatry Reviews Lessons Learned from the Irinotecan Metabolic Pathway
Current Medicinal Chemistry Xenobiotic-Induced Transcriptional Regulation of Xenobiotic Metabolizing Enzymes of the Cytochrome P450 Superfamily in Human Extrahepatic Tissues
Current Drug Metabolism Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update
Current Topics in Medicinal Chemistry Hybrid Molecules Synergistically Acting Against Protein Aggregation Diseases
Current Topics in Medicinal Chemistry Biodegradation Aspects of Carbendazim and Sulfosulfuron: Trends, Scope and Relevance
Current Medicinal Chemistry Green Chemistry Approach as a Versatile Platform for Nanoparticles with Biomedical Applications
Nanoscience & Nanotechnology-Asia Progress in Imaging Agents of Cell Apoptosis
Anti-Cancer Agents in Medicinal Chemistry